Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
A sortable and searchable running inventory of global medtech regulatory and policy official documents, including rules, guidance documents, memos, white papers, and more from national authorities, non-governmental groups, and global organizations.
From routine CT scans, Bunkerhill Health identifies mitral annular calcification—addressing an unmet need as MAC gains recognition as an independent risk factor for heart failure, atrial fibrillation, and cardiac death, and as a driver of complications in mitral valve repair and replacement.
PE deal activity in the medical device sector has been robust, even as other areas of life sciences are struggling to obtain capital. Excerpted from our recent feature article, "Private Equity's Play in Medtech."